Skip to content
Home/Companies/MedTech/CollimateHealth

CollimateHealth

MedTech·Germany·Active·New
Entry
2026
Hold
New
Status
Active

Who owns CollimateHealth?

CollimateHealth is currently owned by Caesar Ventures Management through Caesar Ventures Fund I (2023 vintage), since 2026.

Hand-verified · updated 2026-08-10

Caesar Ventures Management
Investor
Caesar Ventures Management
Caesar Ventures Fund I · 2023 · VC

Key facts

HQGermany
SectorMedTech
StatusActive

More from Caesar Ventures Fund I

Other portfolio companies in the same fund.

Qorelo
Qorelo
Active
SaaSGermany· 2026
Amara
Active
HealthTechGermany· 2025
Freshflow
Active
AI/MLGermany· 2025
Optimeleon
Active
AdTechGermany· 2025
Lucid Genomics
Lucid Genomics
Active
HealthTechGermany· 2024
MEDEA Biopharma
MEDEA Biopharma
Active
BiotechGermany· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Optos
Exited 2015
Amadeus Capital PartnersUK
to
Axomove
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Clee Medical
Clee Medical
Active
High-Tech Gruenderfonds (HTGF)Switzerland· 2026
Custom Surgical
Custom Surgical
Active
ZEISS VenturesGermany· 2026
Track CollimateHealth

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on CollimateHealth.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue